nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—ABCB1—esophageal cancer	0.467	1	CbGaD
Prednisone—SLCO1A2—Methotrexate—esophageal cancer	0.07	0.454	CbGbCtD
Prednisone—ALB—Methotrexate—esophageal cancer	0.0361	0.235	CbGbCtD
Prednisone—ABCB1—Cisplatin—esophageal cancer	0.0291	0.189	CbGbCtD
Prednisone—ABCB1—Methotrexate—esophageal cancer	0.0189	0.123	CbGbCtD
Prednisone—HSD11B1—bronchus—esophageal cancer	0.00565	0.152	CbGeAlD
Prednisone—HSD11B1—smooth muscle tissue—esophageal cancer	0.00553	0.149	CbGeAlD
Prednisone—HSD11B1—trachea—esophageal cancer	0.00508	0.137	CbGeAlD
Prednisone—Rosacea—Capecitabine—esophageal cancer	0.00392	0.0198	CcSEcCtD
Prednisone—Papilloedema—Cisplatin—esophageal cancer	0.00365	0.0184	CcSEcCtD
Prednisone—HSD11B1—lung—esophageal cancer	0.00365	0.0981	CbGeAlD
Prednisone—Arachnoiditis—Methotrexate—esophageal cancer	0.00349	0.0176	CcSEcCtD
Prednisone—Telangiectasia—Methotrexate—esophageal cancer	0.0027	0.0137	CcSEcCtD
Prednisone—Pigmentation disorder—Capecitabine—esophageal cancer	0.00256	0.0129	CcSEcCtD
Prednisone—HSD11B1—lymph node—esophageal cancer	0.00249	0.0671	CbGeAlD
Prednisone—Cognitive impairment—Methotrexate—esophageal cancer	0.00244	0.0123	CcSEcCtD
Prednisone—Amcinonide—ANXA1—esophageal cancer	0.00243	0.232	CrCbGaD
Prednisone—Oesophageal ulcer—Capecitabine—esophageal cancer	0.00235	0.0118	CcSEcCtD
Prednisone—Blood potassium decreased—Capecitabine—esophageal cancer	0.00225	0.0114	CcSEcCtD
Prednisone—Febrile neutropenia—Cisplatin—esophageal cancer	0.00193	0.00975	CcSEcCtD
Prednisone—Optic neuritis—Cisplatin—esophageal cancer	0.00189	0.00953	CcSEcCtD
Prednisone—Osteonecrosis—Methotrexate—esophageal cancer	0.00171	0.00864	CcSEcCtD
Prednisone—Lymphopenia—Capecitabine—esophageal cancer	0.00167	0.00845	CcSEcCtD
Prednisone—NR3C1—neck—esophageal cancer	0.0016	0.043	CbGeAlD
Prednisone—Opportunistic infection—Methotrexate—esophageal cancer	0.00158	0.00799	CcSEcCtD
Prednisone—Dementia—Methotrexate—esophageal cancer	0.00155	0.00784	CcSEcCtD
Prednisone—Leukoderma—Methotrexate—esophageal cancer	0.0015	0.00757	CcSEcCtD
Prednisone—Hypertriglyceridaemia—Capecitabine—esophageal cancer	0.00149	0.00753	CcSEcCtD
Prednisone—Necrosis—Cisplatin—esophageal cancer	0.00148	0.00747	CcSEcCtD
Prednisone—Impaired healing—Methotrexate—esophageal cancer	0.00147	0.00744	CcSEcCtD
Prednisone—Cognitive disorder—Methotrexate—esophageal cancer	0.00147	0.00744	CcSEcCtD
Prednisone—Hirsutism—Capecitabine—esophageal cancer	0.00147	0.00744	CcSEcCtD
Prednisone—Abscess—Cisplatin—esophageal cancer	0.00147	0.00741	CcSEcCtD
Prednisone—Febrile neutropenia—Capecitabine—esophageal cancer	0.00142	0.00719	CcSEcCtD
Prednisone—Infection—Carboplatin—esophageal cancer	0.0014	0.00709	CcSEcCtD
Prednisone—Hypothyroidism—Capecitabine—esophageal cancer	0.00133	0.00673	CcSEcCtD
Prednisone—Embolism—Capecitabine—esophageal cancer	0.00133	0.00673	CcSEcCtD
Prednisone—SLCO1A2—digestive system—esophageal cancer	0.00132	0.0355	CbGeAlD
Prednisone—Blood triglycerides increased—Capecitabine—esophageal cancer	0.00131	0.0066	CcSEcCtD
Prednisone—Ulcer—Cisplatin—esophageal cancer	0.00123	0.0062	CcSEcCtD
Prednisone—Hepatomegaly—Capecitabine—esophageal cancer	0.00121	0.00611	CcSEcCtD
Prednisone—Hiccups—Cisplatin—esophageal cancer	0.00116	0.00586	CcSEcCtD
Prednisone—Osteoporosis—Methotrexate—esophageal cancer	0.00114	0.00574	CcSEcCtD
Prednisone—Body temperature increased—Carboplatin—esophageal cancer	0.00112	0.00564	CcSEcCtD
Prednisone—Skin exfoliation—Cisplatin—esophageal cancer	0.00111	0.0056	CcSEcCtD
Prednisone—Fungal infection—Capecitabine—esophageal cancer	0.00111	0.0056	CcSEcCtD
Prednisone—SLCO1A2—lung—esophageal cancer	0.0011	0.0297	CbGeAlD
Prednisone—Fluid retention—Cisplatin—esophageal cancer	0.0011	0.00557	CcSEcCtD
Prednisone—Multiple fractures—Methotrexate—esophageal cancer	0.0011	0.00554	CcSEcCtD
Prednisone—Fracture—Methotrexate—esophageal cancer	0.0011	0.00554	CcSEcCtD
Prednisone—Memory impairment—Capecitabine—esophageal cancer	0.00109	0.00551	CcSEcCtD
Prednisone—Neuropathy—Cisplatin—esophageal cancer	0.00109	0.00551	CcSEcCtD
Prednisone—NR3C1—epithelium—esophageal cancer	0.00109	0.0292	CbGeAlD
Prednisone—NR3C1—bronchus—esophageal cancer	0.00107	0.0288	CbGeAlD
Prednisone—Febrile neutropenia—Methotrexate—esophageal cancer	0.00106	0.00535	CcSEcCtD
Prednisone—CYP2C19—digestive system—esophageal cancer	0.00106	0.0284	CbGeAlD
Prednisone—NR3C1—smooth muscle tissue—esophageal cancer	0.00105	0.0282	CbGeAlD
Prednisone—Petechiae—Capecitabine—esophageal cancer	0.00104	0.00525	CcSEcCtD
Prednisone—Hydrocortisone—ANXA1—esophageal cancer	0.00103	0.098	CrCbGaD
Prednisone—Exemestane—CYP19A1—esophageal cancer	0.00103	0.098	CrCbGaD
Prednisone—Embolism—Methotrexate—esophageal cancer	0.000993	0.00501	CcSEcCtD
Prednisone—Contusion—Capecitabine—esophageal cancer	0.000981	0.00495	CcSEcCtD
Prednisone—Testolactone—CYP19A1—esophageal cancer	0.000978	0.0935	CrCbGaD
Prednisone—NR3C1—trachea—esophageal cancer	0.000961	0.0258	CbGeAlD
Prednisone—Cardiac failure congestive—Cisplatin—esophageal cancer	0.000929	0.00469	CcSEcCtD
Prednisone—Ulcer—Capecitabine—esophageal cancer	0.000905	0.00457	CcSEcCtD
Prednisone—Cataract—Capecitabine—esophageal cancer	0.000899	0.00454	CcSEcCtD
Prednisone—Amnesia—Cisplatin—esophageal cancer	0.000897	0.00453	CcSEcCtD
Prednisone—Hiccups—Capecitabine—esophageal cancer	0.000856	0.00432	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.000843	0.00426	CcSEcCtD
Prednisone—NR3C1—digestive system—esophageal cancer	0.000827	0.0222	CbGeAlD
Prednisone—Fungal infection—Methotrexate—esophageal cancer	0.000825	0.00417	CcSEcCtD
Prednisone—Skin exfoliation—Capecitabine—esophageal cancer	0.000817	0.00413	CcSEcCtD
Prednisone—Face oedema—Cisplatin—esophageal cancer	0.000814	0.00411	CcSEcCtD
Prednisone—Fluid retention—Capecitabine—esophageal cancer	0.000813	0.0041	CcSEcCtD
Prednisone—Necrosis—Methotrexate—esophageal cancer	0.000812	0.0041	CcSEcCtD
Prednisone—Abscess—Methotrexate—esophageal cancer	0.000805	0.00407	CcSEcCtD
Prednisone—Irritability—Cisplatin—esophageal cancer	0.000804	0.00406	CcSEcCtD
Prednisone—Neuropathy—Capecitabine—esophageal cancer	0.000804	0.00406	CcSEcCtD
Prednisone—Oesophagitis—Capecitabine—esophageal cancer	0.000782	0.00395	CcSEcCtD
Prednisone—Petechiae—Methotrexate—esophageal cancer	0.000774	0.00391	CcSEcCtD
Prednisone—Ecchymosis—Capecitabine—esophageal cancer	0.000774	0.00391	CcSEcCtD
Prednisone—Hypokalaemia—Cisplatin—esophageal cancer	0.000767	0.00387	CcSEcCtD
Prednisone—Dexamethasone—ANXA1—esophageal cancer	0.000764	0.073	CrCbGaD
Prednisone—ALB—lymph node—esophageal cancer	0.00075	0.0202	CbGeAlD
Prednisone—Sepsis—Capecitabine—esophageal cancer	0.000743	0.00375	CcSEcCtD
Prednisone—Thrombophlebitis—Capecitabine—esophageal cancer	0.000718	0.00362	CcSEcCtD
Prednisone—Diabetes mellitus—Capecitabine—esophageal cancer	0.000714	0.00361	CcSEcCtD
Prednisone—Pancreatitis—Cisplatin—esophageal cancer	0.000714	0.00361	CcSEcCtD
Prednisone—Sweating increased—Cisplatin—esophageal cancer	0.00071	0.00358	CcSEcCtD
Prednisone—Vascular purpura—Capecitabine—esophageal cancer	0.000695	0.00351	CcSEcCtD
Prednisone—NR3C1—lung—esophageal cancer	0.00069	0.0186	CbGeAlD
Prednisone—Ulcer—Methotrexate—esophageal cancer	0.000674	0.0034	CcSEcCtD
Prednisone—Increased appetite—Capecitabine—esophageal cancer	0.000661	0.00334	CcSEcCtD
Prednisone—Amnesia—Capecitabine—esophageal cancer	0.000661	0.00334	CcSEcCtD
Prednisone—Vasculitis—Methotrexate—esophageal cancer	0.000653	0.0033	CcSEcCtD
Prednisone—Purpura—Capecitabine—esophageal cancer	0.000645	0.00326	CcSEcCtD
Prednisone—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00064	0.00323	CcSEcCtD
Prednisone—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000637	0.00322	CcSEcCtD
Prednisone—Myocardial infarction—Cisplatin—esophageal cancer	0.000637	0.00322	CcSEcCtD
Prednisone—Cardiac failure—Capecitabine—esophageal cancer	0.000637	0.00322	CcSEcCtD
Prednisone—Lethargy—Capecitabine—esophageal cancer	0.000634	0.0032	CcSEcCtD
Prednisone—CYP3A4—digestive system—esophageal cancer	0.000625	0.0168	CbGeAlD
Prednisone—Osteoarthritis—Capecitabine—esophageal cancer	0.000621	0.00314	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000621	0.00314	CcSEcCtD
Prednisone—Skin exfoliation—Methotrexate—esophageal cancer	0.000608	0.00307	CcSEcCtD
Prednisone—Face oedema—Capecitabine—esophageal cancer	0.0006	0.00303	CcSEcCtD
Prednisone—Bradycardia—Cisplatin—esophageal cancer	0.000594	0.003	CcSEcCtD
Prednisone—Irritability—Capecitabine—esophageal cancer	0.000593	0.00299	CcSEcCtD
Prednisone—Cardiac arrest—Capecitabine—esophageal cancer	0.000591	0.00298	CcSEcCtD
Prednisone—Mood swings—Capecitabine—esophageal cancer	0.000589	0.00297	CcSEcCtD
Prednisone—ABCB1—epithelium—esophageal cancer	0.000582	0.0156	CbGeAlD
Prednisone—Ecchymosis—Methotrexate—esophageal cancer	0.000576	0.00291	CcSEcCtD
Prednisone—Connective tissue disorder—Cisplatin—esophageal cancer	0.000573	0.00289	CcSEcCtD
Prednisone—Dry skin—Capecitabine—esophageal cancer	0.000569	0.00288	CcSEcCtD
Prednisone—Pulmonary oedema—Methotrexate—esophageal cancer	0.000567	0.00286	CcSEcCtD
Prednisone—Hypokalaemia—Capecitabine—esophageal cancer	0.000565	0.00286	CcSEcCtD
Prednisone—Sepsis—Methotrexate—esophageal cancer	0.000553	0.00279	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000548	0.00277	CcSEcCtD
Prednisone—Muscular weakness—Capecitabine—esophageal cancer	0.000548	0.00277	CcSEcCtD
Prednisone—Eye disorder—Cisplatin—esophageal cancer	0.000545	0.00275	CcSEcCtD
Prednisone—Flushing—Cisplatin—esophageal cancer	0.000541	0.00273	CcSEcCtD
Prednisone—Abdominal distension—Capecitabine—esophageal cancer	0.000541	0.00273	CcSEcCtD
Prednisone—Thrombophlebitis—Methotrexate—esophageal cancer	0.000534	0.0027	CcSEcCtD
Prednisone—Diabetes mellitus—Methotrexate—esophageal cancer	0.000532	0.00269	CcSEcCtD
Prednisone—Immune system disorder—Cisplatin—esophageal cancer	0.000527	0.00266	CcSEcCtD
Prednisone—Sweating increased—Capecitabine—esophageal cancer	0.000523	0.00264	CcSEcCtD
Prednisone—Arrhythmia—Cisplatin—esophageal cancer	0.000521	0.00263	CcSEcCtD
Prednisone—Alopecia—Cisplatin—esophageal cancer	0.000515	0.0026	CcSEcCtD
Prednisone—ABCB1—trachea—esophageal cancer	0.000514	0.0138	CbGeAlD
Prednisone—Erythema—Cisplatin—esophageal cancer	0.000508	0.00256	CcSEcCtD
Prednisone—Malnutrition—Cisplatin—esophageal cancer	0.000508	0.00256	CcSEcCtD
Prednisone—Neutropenia—Capecitabine—esophageal cancer	0.000502	0.00254	CcSEcCtD
Prednisone—Weight increased—Capecitabine—esophageal cancer	0.000489	0.00247	CcSEcCtD
Prednisone—Weight decreased—Capecitabine—esophageal cancer	0.000486	0.00245	CcSEcCtD
Prednisone—Hyperglycaemia—Capecitabine—esophageal cancer	0.000484	0.00245	CcSEcCtD
Prednisone—Vision blurred—Cisplatin—esophageal cancer	0.000478	0.00242	CcSEcCtD
Prednisone—Depression—Capecitabine—esophageal cancer	0.000477	0.00241	CcSEcCtD
Prednisone—NR3C1—lymph node—esophageal cancer	0.000472	0.0127	CbGeAlD
Prednisone—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000472	0.00238	CcSEcCtD
Prednisone—Lethargy—Methotrexate—esophageal cancer	0.000472	0.00238	CcSEcCtD
Prednisone—Ill-defined disorder—Cisplatin—esophageal cancer	0.000471	0.00238	CcSEcCtD
Prednisone—Danazol—CYP19A1—esophageal cancer	0.000471	0.045	CrCbGaD
Prednisone—Myocardial infarction—Capecitabine—esophageal cancer	0.000469	0.00237	CcSEcCtD
Prednisone—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000469	0.00237	CcSEcCtD
Prednisone—Anaemia—Cisplatin—esophageal cancer	0.000469	0.00237	CcSEcCtD
Prednisone—Osteoarthritis—Methotrexate—esophageal cancer	0.000463	0.00234	CcSEcCtD
Prednisone—Malaise—Cisplatin—esophageal cancer	0.000458	0.00231	CcSEcCtD
Prednisone—ABCB1—digestive system—esophageal cancer	0.000443	0.0119	CbGeAlD
Prednisone—Irritability—Methotrexate—esophageal cancer	0.000441	0.00223	CcSEcCtD
Prednisone—Convulsion—Cisplatin—esophageal cancer	0.00044	0.00222	CcSEcCtD
Prednisone—Mood swings—Methotrexate—esophageal cancer	0.000438	0.00221	CcSEcCtD
Prednisone—Bradycardia—Capecitabine—esophageal cancer	0.000438	0.00221	CcSEcCtD
Prednisone—Myalgia—Cisplatin—esophageal cancer	0.000432	0.00218	CcSEcCtD
Prednisone—Haemoglobin—Capecitabine—esophageal cancer	0.000432	0.00218	CcSEcCtD
Prednisone—Anxiety—Cisplatin—esophageal cancer	0.000431	0.00217	CcSEcCtD
Prednisone—Haemorrhage—Capecitabine—esophageal cancer	0.00043	0.00217	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000429	0.00217	CcSEcCtD
Prednisone—Discomfort—Cisplatin—esophageal cancer	0.000427	0.00216	CcSEcCtD
Prednisone—Connective tissue disorder—Capecitabine—esophageal cancer	0.000422	0.00213	CcSEcCtD
Prednisone—Anaphylactic shock—Cisplatin—esophageal cancer	0.000414	0.00209	CcSEcCtD
Prednisone—Oedema—Cisplatin—esophageal cancer	0.000414	0.00209	CcSEcCtD
Prednisone—Infection—Cisplatin—esophageal cancer	0.000412	0.00208	CcSEcCtD
Prednisone—Prednisolone—CYP2A6—esophageal cancer	0.000411	0.0393	CrCbGaD
Prednisone—Nervous system disorder—Cisplatin—esophageal cancer	0.000406	0.00205	CcSEcCtD
Prednisone—Tachycardia—Cisplatin—esophageal cancer	0.000404	0.00204	CcSEcCtD
Prednisone—Skin disorder—Cisplatin—esophageal cancer	0.000402	0.00203	CcSEcCtD
Prednisone—Eye disorder—Capecitabine—esophageal cancer	0.000402	0.00203	CcSEcCtD
Prednisone—Hyperhidrosis—Cisplatin—esophageal cancer	0.0004	0.00202	CcSEcCtD
Prednisone—Flushing—Capecitabine—esophageal cancer	0.000399	0.00201	CcSEcCtD
Prednisone—Methyltestosterone—CYP19A1—esophageal cancer	0.000398	0.038	CrCbGaD
Prednisone—Anorexia—Cisplatin—esophageal cancer	0.000395	0.00199	CcSEcCtD
Prednisone—Pancreatitis—Methotrexate—esophageal cancer	0.000392	0.00198	CcSEcCtD
Prednisone—Angiopathy—Capecitabine—esophageal cancer	0.00039	0.00197	CcSEcCtD
Prednisone—Immune system disorder—Capecitabine—esophageal cancer	0.000388	0.00196	CcSEcCtD
Prednisone—Arrhythmia—Capecitabine—esophageal cancer	0.000384	0.00194	CcSEcCtD
Prednisone—Betamethasone—CYP19A1—esophageal cancer	0.000384	0.0367	CrCbGaD
Prednisone—Alopecia—Capecitabine—esophageal cancer	0.00038	0.00192	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000377	0.00191	CcSEcCtD
Prednisone—Mental disorder—Capecitabine—esophageal cancer	0.000377	0.0019	CcSEcCtD
Prednisone—Erythema—Capecitabine—esophageal cancer	0.000374	0.00189	CcSEcCtD
Prednisone—Malnutrition—Capecitabine—esophageal cancer	0.000374	0.00189	CcSEcCtD
Prednisone—Neutropenia—Methotrexate—esophageal cancer	0.000374	0.00189	CcSEcCtD
Prednisone—Paraesthesia—Cisplatin—esophageal cancer	0.000372	0.00188	CcSEcCtD
Prednisone—ABCB1—lung—esophageal cancer	0.00037	0.00994	CbGeAlD
Prednisone—Erectile dysfunction—Methotrexate—esophageal cancer	0.000368	0.00186	CcSEcCtD
Prednisone—Decreased appetite—Cisplatin—esophageal cancer	0.00036	0.00182	CcSEcCtD
Prednisone—Dexamethasone—NOS2—esophageal cancer	0.000358	0.0342	CrCbGaD
Prednisone—Depression—Methotrexate—esophageal cancer	0.000355	0.00179	CcSEcCtD
Prednisone—Vision blurred—Capecitabine—esophageal cancer	0.000353	0.00178	CcSEcCtD
Prednisone—Ill-defined disorder—Capecitabine—esophageal cancer	0.000347	0.00175	CcSEcCtD
Prednisone—Anaemia—Capecitabine—esophageal cancer	0.000346	0.00175	CcSEcCtD
Prednisone—Feeling abnormal—Cisplatin—esophageal cancer	0.000341	0.00172	CcSEcCtD
Prednisone—Malaise—Capecitabine—esophageal cancer	0.000337	0.0017	CcSEcCtD
Prednisone—Vertigo—Capecitabine—esophageal cancer	0.000336	0.0017	CcSEcCtD
Prednisone—Syncope—Capecitabine—esophageal cancer	0.000336	0.00169	CcSEcCtD
Prednisone—Loss of consciousness—Capecitabine—esophageal cancer	0.000329	0.00166	CcSEcCtD
Prednisone—Body temperature increased—Cisplatin—esophageal cancer	0.000327	0.00165	CcSEcCtD
Prednisone—Hypertension—Capecitabine—esophageal cancer	0.000323	0.00163	CcSEcCtD
Prednisone—Haemoglobin—Methotrexate—esophageal cancer	0.000322	0.00162	CcSEcCtD
Prednisone—Haemorrhage—Methotrexate—esophageal cancer	0.00032	0.00162	CcSEcCtD
Prednisone—Arthralgia—Capecitabine—esophageal cancer	0.000319	0.00161	CcSEcCtD
Prednisone—Myalgia—Capecitabine—esophageal cancer	0.000319	0.00161	CcSEcCtD
Prednisone—Anxiety—Capecitabine—esophageal cancer	0.000317	0.0016	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000316	0.0016	CcSEcCtD
Prednisone—Discomfort—Capecitabine—esophageal cancer	0.000315	0.00159	CcSEcCtD
Prednisone—Oedema—Capecitabine—esophageal cancer	0.000305	0.00154	CcSEcCtD
Prednisone—Hypersensitivity—Cisplatin—esophageal cancer	0.000305	0.00154	CcSEcCtD
Prednisone—Dexamethasone—CYP1B1—esophageal cancer	0.000304	0.0291	CrCbGaD
Prednisone—Infection—Capecitabine—esophageal cancer	0.000303	0.00153	CcSEcCtD
Prednisone—Shock—Capecitabine—esophageal cancer	0.0003	0.00152	CcSEcCtD
Prednisone—Nervous system disorder—Capecitabine—esophageal cancer	0.000299	0.00151	CcSEcCtD
Prednisone—Eye disorder—Methotrexate—esophageal cancer	0.000299	0.00151	CcSEcCtD
Prednisone—Tachycardia—Capecitabine—esophageal cancer	0.000298	0.00151	CcSEcCtD
Prednisone—Asthenia—Cisplatin—esophageal cancer	0.000297	0.0015	CcSEcCtD
Prednisone—Skin disorder—Capecitabine—esophageal cancer	0.000297	0.0015	CcSEcCtD
Prednisone—Hyperhidrosis—Capecitabine—esophageal cancer	0.000295	0.00149	CcSEcCtD
Prednisone—Anorexia—Capecitabine—esophageal cancer	0.000291	0.00147	CcSEcCtD
Prednisone—Angiopathy—Methotrexate—esophageal cancer	0.00029	0.00147	CcSEcCtD
Prednisone—Immune system disorder—Methotrexate—esophageal cancer	0.000289	0.00146	CcSEcCtD
Prednisone—Diarrhoea—Cisplatin—esophageal cancer	0.000283	0.00143	CcSEcCtD
Prednisone—Alopecia—Methotrexate—esophageal cancer	0.000283	0.00143	CcSEcCtD
Prednisone—Mental disorder—Methotrexate—esophageal cancer	0.00028	0.00142	CcSEcCtD
Prednisone—Erythema—Methotrexate—esophageal cancer	0.000279	0.00141	CcSEcCtD
Prednisone—Malnutrition—Methotrexate—esophageal cancer	0.000279	0.00141	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000278	0.00141	CcSEcCtD
Prednisone—Insomnia—Capecitabine—esophageal cancer	0.000276	0.00139	CcSEcCtD
Prednisone—Paraesthesia—Capecitabine—esophageal cancer	0.000274	0.00138	CcSEcCtD
Prednisone—Dyspepsia—Capecitabine—esophageal cancer	0.000269	0.00136	CcSEcCtD
Prednisone—Decreased appetite—Capecitabine—esophageal cancer	0.000265	0.00134	CcSEcCtD
Prednisone—Vomiting—Cisplatin—esophageal cancer	0.000263	0.00133	CcSEcCtD
Prednisone—Fatigue—Capecitabine—esophageal cancer	0.000263	0.00133	CcSEcCtD
Prednisone—Vision blurred—Methotrexate—esophageal cancer	0.000262	0.00133	CcSEcCtD
Prednisone—Rash—Cisplatin—esophageal cancer	0.000261	0.00132	CcSEcCtD
Prednisone—Constipation—Capecitabine—esophageal cancer	0.000261	0.00132	CcSEcCtD
Prednisone—Dermatitis—Cisplatin—esophageal cancer	0.000261	0.00132	CcSEcCtD
Prednisone—Ill-defined disorder—Methotrexate—esophageal cancer	0.000258	0.00131	CcSEcCtD
Prednisone—Anaemia—Methotrexate—esophageal cancer	0.000257	0.0013	CcSEcCtD
Prednisone—ABCB1—lymph node—esophageal cancer	0.000253	0.0068	CbGeAlD
Prednisone—Feeling abnormal—Capecitabine—esophageal cancer	0.000252	0.00127	CcSEcCtD
Prednisone—Malaise—Methotrexate—esophageal cancer	0.000251	0.00127	CcSEcCtD
Prednisone—Vertigo—Methotrexate—esophageal cancer	0.00025	0.00126	CcSEcCtD
Prednisone—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00025	0.00126	CcSEcCtD
Prednisone—Nausea—Cisplatin—esophageal cancer	0.000246	0.00124	CcSEcCtD
Prednisone—Urticaria—Capecitabine—esophageal cancer	0.000243	0.00123	CcSEcCtD
Prednisone—Abdominal pain—Capecitabine—esophageal cancer	0.000241	0.00122	CcSEcCtD
Prednisone—Body temperature increased—Capecitabine—esophageal cancer	0.000241	0.00122	CcSEcCtD
Prednisone—Convulsion—Methotrexate—esophageal cancer	0.000241	0.00122	CcSEcCtD
Prednisone—Dexamethasone—ABCC2—esophageal cancer	0.000237	0.0227	CrCbGaD
Prednisone—Myalgia—Methotrexate—esophageal cancer	0.000237	0.0012	CcSEcCtD
Prednisone—Arthralgia—Methotrexate—esophageal cancer	0.000237	0.0012	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000235	0.00119	CcSEcCtD
Prednisone—Dexamethasone—CYP2A6—esophageal cancer	0.000234	0.0224	CrCbGaD
Prednisone—Discomfort—Methotrexate—esophageal cancer	0.000234	0.00118	CcSEcCtD
Prednisone—Anaphylactic shock—Methotrexate—esophageal cancer	0.000227	0.00115	CcSEcCtD
Prednisone—Infection—Methotrexate—esophageal cancer	0.000226	0.00114	CcSEcCtD
Prednisone—Hypersensitivity—Capecitabine—esophageal cancer	0.000225	0.00114	CcSEcCtD
Prednisone—Dexamethasone—CYP19A1—esophageal cancer	0.000223	0.0213	CrCbGaD
Prednisone—Nervous system disorder—Methotrexate—esophageal cancer	0.000223	0.00113	CcSEcCtD
Prednisone—Skin disorder—Methotrexate—esophageal cancer	0.000221	0.00112	CcSEcCtD
Prednisone—Hyperhidrosis—Methotrexate—esophageal cancer	0.00022	0.00111	CcSEcCtD
Prednisone—Asthenia—Capecitabine—esophageal cancer	0.000219	0.00111	CcSEcCtD
Prednisone—Methylprednisolone—ABCB1—esophageal cancer	0.000217	0.0208	CrCbGaD
Prednisone—Anorexia—Methotrexate—esophageal cancer	0.000217	0.00109	CcSEcCtD
Prednisone—Pruritus—Capecitabine—esophageal cancer	0.000216	0.00109	CcSEcCtD
Prednisone—Triamcinolone—PTGS2—esophageal cancer	0.000215	0.0206	CrCbGaD
Prednisone—Diarrhoea—Capecitabine—esophageal cancer	0.000209	0.00106	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000207	0.00105	CcSEcCtD
Prednisone—Insomnia—Methotrexate—esophageal cancer	0.000206	0.00104	CcSEcCtD
Prednisone—Paraesthesia—Methotrexate—esophageal cancer	0.000204	0.00103	CcSEcCtD
Prednisone—Dizziness—Capecitabine—esophageal cancer	0.000202	0.00102	CcSEcCtD
Prednisone—Dyspepsia—Methotrexate—esophageal cancer	0.0002	0.00101	CcSEcCtD
Prednisone—Decreased appetite—Methotrexate—esophageal cancer	0.000198	0.000998	CcSEcCtD
Prednisone—Fatigue—Methotrexate—esophageal cancer	0.000196	0.00099	CcSEcCtD
Prednisone—Vomiting—Capecitabine—esophageal cancer	0.000194	0.000981	CcSEcCtD
Prednisone—Rash—Capecitabine—esophageal cancer	0.000193	0.000972	CcSEcCtD
Prednisone—Dermatitis—Capecitabine—esophageal cancer	0.000192	0.000971	CcSEcCtD
Prednisone—Headache—Capecitabine—esophageal cancer	0.000191	0.000966	CcSEcCtD
Prednisone—Feeling abnormal—Methotrexate—esophageal cancer	0.000187	0.000946	CcSEcCtD
Prednisone—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000186	0.000939	CcSEcCtD
Prednisone—Nausea—Capecitabine—esophageal cancer	0.000181	0.000916	CcSEcCtD
Prednisone—Urticaria—Methotrexate—esophageal cancer	0.000181	0.000912	CcSEcCtD
Prednisone—Body temperature increased—Methotrexate—esophageal cancer	0.00018	0.000908	CcSEcCtD
Prednisone—Abdominal pain—Methotrexate—esophageal cancer	0.00018	0.000908	CcSEcCtD
Prednisone—Betamethasone—PTGS2—esophageal cancer	0.000176	0.0169	CrCbGaD
Prednisone—Hypersensitivity—Methotrexate—esophageal cancer	0.000167	0.000846	CcSEcCtD
Prednisone—Asthenia—Methotrexate—esophageal cancer	0.000163	0.000824	CcSEcCtD
Prednisone—Pruritus—Methotrexate—esophageal cancer	0.000161	0.000812	CcSEcCtD
Prednisone—Diarrhoea—Methotrexate—esophageal cancer	0.000156	0.000785	CcSEcCtD
Prednisone—Prednisolone—ABCB1—esophageal cancer	0.000153	0.0146	CrCbGaD
Prednisone—Dizziness—Methotrexate—esophageal cancer	0.00015	0.000759	CcSEcCtD
Prednisone—Betamethasone—ABCB1—esophageal cancer	0.00015	0.0143	CrCbGaD
Prednisone—Vomiting—Methotrexate—esophageal cancer	0.000145	0.00073	CcSEcCtD
Prednisone—Rash—Methotrexate—esophageal cancer	0.000143	0.000724	CcSEcCtD
Prednisone—Dermatitis—Methotrexate—esophageal cancer	0.000143	0.000723	CcSEcCtD
Prednisone—Headache—Methotrexate—esophageal cancer	0.000142	0.000719	CcSEcCtD
Prednisone—Nausea—Methotrexate—esophageal cancer	0.000135	0.000682	CcSEcCtD
Prednisone—Hydrocortisone—ABCB1—esophageal cancer	0.000117	0.0112	CrCbGaD
Prednisone—Dexamethasone—PTGS2—esophageal cancer	0.000103	0.00981	CrCbGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	9.42e-05	0.000706	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—NOTCH2—esophageal cancer	9.32e-05	0.000698	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—EP300—esophageal cancer	9.19e-05	0.000689	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	9.13e-05	0.000685	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	9.08e-05	0.000681	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	9.01e-05	0.000675	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	8.73e-05	0.000655	CbGpPWpGaD
Prednisone—Dexamethasone—ABCB1—esophageal cancer	8.73e-05	0.00834	CrCbGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	8.71e-05	0.000653	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	8.64e-05	0.000648	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	8.54e-05	0.00064	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	8.46e-05	0.000634	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—EP300—esophageal cancer	8.43e-05	0.000632	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ADH1B—esophageal cancer	8.36e-05	0.000627	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	8.35e-05	0.000626	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	8.35e-05	0.000626	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	8.31e-05	0.000623	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	8.17e-05	0.000613	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	8.09e-05	0.000607	CbGpPWpGaD
Prednisone—ALB—Hemostasis—CFL1—esophageal cancer	8.03e-05	0.000602	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	8e-05	0.0006	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—TYMP—esophageal cancer	7.99e-05	0.000599	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—NR1I2—esophageal cancer	7.96e-05	0.000597	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	7.85e-05	0.000588	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—SMAD4—esophageal cancer	7.82e-05	0.000586	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP26A1—esophageal cancer	7.77e-05	0.000582	CbGpPWpGaD
Prednisone—ALB—Hemostasis—GNG7—esophageal cancer	7.57e-05	0.000568	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ALOX15—esophageal cancer	7.57e-05	0.000568	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	7.46e-05	0.000559	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—TP53—esophageal cancer	7.36e-05	0.000552	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	7.25e-05	0.000543	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—ABCC2—esophageal cancer	7.22e-05	0.000542	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GSTO1—esophageal cancer	7.22e-05	0.000542	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—TPI1—esophageal cancer	7.22e-05	0.000542	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ALDOB—esophageal cancer	6.93e-05	0.000519	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	6.88e-05	0.000516	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—HIST1H2BM—esophageal cancer	6.83e-05	0.000512	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PIK3CA—esophageal cancer	6.8e-05	0.000509	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	6.79e-05	0.000509	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GAPDH—esophageal cancer	6.67e-05	0.0005	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CRABP1—esophageal cancer	6.61e-05	0.000495	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—GNG7—esophageal cancer	6.56e-05	0.000491	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	6.51e-05	0.000488	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	6.47e-05	0.000485	CbGpPWpGaD
Prednisone—ALB—Metabolism—BLVRB—esophageal cancer	6.44e-05	0.000483	CbGpPWpGaD
Prednisone—ALB—Metabolism—SLC52A3—esophageal cancer	6.44e-05	0.000483	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	6.38e-05	0.000478	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	6.33e-05	0.000475	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GNG7—esophageal cancer	6.28e-05	0.000471	CbGpPWpGaD
Prednisone—ALB—Hemostasis—HSPA5—esophageal cancer	6.17e-05	0.000463	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ALDH2—esophageal cancer	5.89e-05	0.000441	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—BLVRB—esophageal cancer	5.78e-05	0.000433	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—SLC52A3—esophageal cancer	5.78e-05	0.000433	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—NOTCH1—esophageal cancer	5.77e-05	0.000432	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	5.76e-05	0.000432	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	5.74e-05	0.000431	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	5.68e-05	0.000426	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	5.65e-05	0.000424	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—BLVRB—esophageal cancer	5.64e-05	0.000423	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SLC52A3—esophageal cancer	5.64e-05	0.000423	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GSTT1—esophageal cancer	5.6e-05	0.00042	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP2A6—esophageal cancer	5.54e-05	0.000415	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.51e-05	0.000413	CbGpPWpGaD
Prednisone—ALB—Metabolism—CA1—esophageal cancer	5.48e-05	0.000411	CbGpPWpGaD
Prednisone—ALB—Metabolism—SLC10A2—esophageal cancer	5.48e-05	0.000411	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PSME1—esophageal cancer	5.3e-05	0.000397	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PSME2—esophageal cancer	5.3e-05	0.000397	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ENO1—esophageal cancer	5.25e-05	0.000393	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTGS1—esophageal cancer	5.25e-05	0.000393	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.24e-05	0.000393	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—CREBBP—esophageal cancer	5.23e-05	0.000392	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PSME1—esophageal cancer	5.17e-05	0.000388	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PSME2—esophageal cancer	5.17e-05	0.000388	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	5.17e-05	0.000388	CbGpPWpGaD
Prednisone—ALB—Metabolism—CA2—esophageal cancer	5.01e-05	0.000376	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—NOTCH3—esophageal cancer	5e-05	0.000375	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—SLC10A2—esophageal cancer	4.92e-05	0.000369	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CA1—esophageal cancer	4.92e-05	0.000369	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	4.9e-05	0.000367	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	4.87e-05	0.000365	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SLC10A2—esophageal cancer	4.8e-05	0.00036	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CA1—esophageal cancer	4.8e-05	0.00036	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	4.73e-05	0.000355	CbGpPWpGaD
Prednisone—ALB—Metabolism—PLCE1—esophageal cancer	4.66e-05	0.000349	CbGpPWpGaD
Prednisone—ALB—Metabolism—ADH7—esophageal cancer	4.66e-05	0.000349	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	4.63e-05	0.000347	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.6e-05	0.000345	CbGpPWpGaD
Prednisone—ALB—Hemostasis—ABL1—esophageal cancer	4.57e-05	0.000343	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.52e-05	0.000339	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CA2—esophageal cancer	4.5e-05	0.000337	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—NOTCH2—esophageal cancer	4.48e-05	0.000336	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP1B1—esophageal cancer	4.46e-05	0.000335	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	4.39e-05	0.000329	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CA2—esophageal cancer	4.39e-05	0.000329	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP19A1—esophageal cancer	4.2e-05	0.000315	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	4.18e-05	0.000314	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ADH7—esophageal cancer	4.18e-05	0.000313	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PLCE1—esophageal cancer	4.18e-05	0.000313	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.13e-05	0.00031	CbGpPWpGaD
Prednisone—ALB—Metabolism—ADH1B—esophageal cancer	4.08e-05	0.000306	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PLCE1—esophageal cancer	4.08e-05	0.000306	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ADH7—esophageal cancer	4.08e-05	0.000306	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	4.05e-05	0.000303	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.99e-05	0.000299	CbGpPWpGaD
Prednisone—ALB—Metabolism—TYMP—esophageal cancer	3.9e-05	0.000293	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	3.85e-05	0.000289	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.83e-05	0.000287	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—HMOX1—esophageal cancer	3.83e-05	0.000287	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP26A1—esophageal cancer	3.8e-05	0.000285	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—SMAD4—esophageal cancer	3.77e-05	0.000282	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.76e-05	0.000282	CbGpPWpGaD
Prednisone—ALB—Metabolism—ALOX15—esophageal cancer	3.7e-05	0.000277	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ABCB1—esophageal cancer	3.67e-05	0.000276	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ADH1B—esophageal cancer	3.67e-05	0.000275	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ADH1B—esophageal cancer	3.58e-05	0.000268	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTO1—esophageal cancer	3.53e-05	0.000265	CbGpPWpGaD
Prednisone—ALB—Metabolism—TPI1—esophageal cancer	3.53e-05	0.000265	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—TYMP—esophageal cancer	3.5e-05	0.000263	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.5e-05	0.000262	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SLC52A3—esophageal cancer	3.48e-05	0.000261	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—BLVRB—esophageal cancer	3.48e-05	0.000261	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—TYMP—esophageal cancer	3.42e-05	0.000256	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP26A1—esophageal cancer	3.41e-05	0.000255	CbGpPWpGaD
Prednisone—ALB—Metabolism—ALDOB—esophageal cancer	3.38e-05	0.000254	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	3.36e-05	0.000252	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP26A1—esophageal cancer	3.33e-05	0.000249	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ALOX15—esophageal cancer	3.32e-05	0.000249	CbGpPWpGaD
Prednisone—ALB—Hemostasis—NOS2—esophageal cancer	3.3e-05	0.000247	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	3.28e-05	0.000246	CbGpPWpGaD
Prednisone—ALB—Metabolism—GAPDH—esophageal cancer	3.26e-05	0.000244	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ALOX15—esophageal cancer	3.24e-05	0.000243	CbGpPWpGaD
Prednisone—ALB—Metabolism—CRABP1—esophageal cancer	3.23e-05	0.000242	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTO1—esophageal cancer	3.17e-05	0.000238	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—TPI1—esophageal cancer	3.17e-05	0.000238	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—MYC—esophageal cancer	3.1e-05	0.000233	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—TPI1—esophageal cancer	3.09e-05	0.000232	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTO1—esophageal cancer	3.09e-05	0.000232	CbGpPWpGaD
Prednisone—ALB—Metabolism—GNG7—esophageal cancer	3.07e-05	0.00023	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ALDOB—esophageal cancer	3.04e-05	0.000228	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ALDOB—esophageal cancer	2.96e-05	0.000222	CbGpPWpGaD
Prednisone—ALB—Hemostasis—CREBBP—esophageal cancer	2.96e-05	0.000222	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CA1—esophageal cancer	2.96e-05	0.000222	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.96e-05	0.000222	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GAPDH—esophageal cancer	2.92e-05	0.000219	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CRABP1—esophageal cancer	2.9e-05	0.000217	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	2.89e-05	0.000217	CbGpPWpGaD
Prednisone—ALB—Metabolism—ALDH2—esophageal cancer	2.88e-05	0.000216	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GAPDH—esophageal cancer	2.85e-05	0.000214	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.85e-05	0.000214	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CRABP1—esophageal cancer	2.83e-05	0.000212	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.78e-05	0.000208	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—NOTCH1—esophageal cancer	2.78e-05	0.000208	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GNG7—esophageal cancer	2.76e-05	0.000207	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.76e-05	0.000207	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTT1—esophageal cancer	2.74e-05	0.000205	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP2A6—esophageal cancer	2.7e-05	0.000203	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CA2—esophageal cancer	2.7e-05	0.000203	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.69e-05	0.000202	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GNG7—esophageal cancer	2.69e-05	0.000202	CbGpPWpGaD
Prednisone—ALB—Hemostasis—NOS3—esophageal cancer	2.65e-05	0.000199	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ALDH2—esophageal cancer	2.58e-05	0.000194	CbGpPWpGaD
Prednisone—ALB—Metabolism—ENO1—esophageal cancer	2.56e-05	0.000192	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTGS1—esophageal cancer	2.56e-05	0.000192	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.56e-05	0.000192	CbGpPWpGaD
Prednisone—ALB—Metabolism—PSME2—esophageal cancer	2.53e-05	0.000189	CbGpPWpGaD
Prednisone—ALB—Metabolism—PSME1—esophageal cancer	2.53e-05	0.000189	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ALDH2—esophageal cancer	2.52e-05	0.000189	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—CREBBP—esophageal cancer	2.52e-05	0.000189	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ADH7—esophageal cancer	2.51e-05	0.000188	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.51e-05	0.000188	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTT1—esophageal cancer	2.46e-05	0.000184	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CREBBP—esophageal cancer	2.46e-05	0.000184	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP2A6—esophageal cancer	2.43e-05	0.000182	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.42e-05	0.000181	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTT1—esophageal cancer	2.4e-05	0.00018	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP2A6—esophageal cancer	2.37e-05	0.000178	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ENO1—esophageal cancer	2.3e-05	0.000173	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTGS1—esophageal cancer	2.3e-05	0.000173	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PSME2—esophageal cancer	2.27e-05	0.00017	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PSME1—esophageal cancer	2.27e-05	0.00017	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTGS1—esophageal cancer	2.25e-05	0.000168	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ENO1—esophageal cancer	2.25e-05	0.000168	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.24e-05	0.000168	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PSME2—esophageal cancer	2.21e-05	0.000166	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PSME1—esophageal cancer	2.21e-05	0.000166	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.21e-05	0.000165	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ADH1B—esophageal cancer	2.2e-05	0.000165	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—NOS3—esophageal cancer	2.2e-05	0.000165	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP1B1—esophageal cancer	2.18e-05	0.000163	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—TYMP—esophageal cancer	2.11e-05	0.000158	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP19A1—esophageal cancer	2.05e-05	0.000154	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.05e-05	0.000154	CbGpPWpGaD
Prednisone—ALB—Hemostasis—EP300—esophageal cancer	2.02e-05	0.000151	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTGS2—esophageal cancer	2.01e-05	0.000151	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ALOX15—esophageal cancer	2e-05	0.00015	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.98e-05	0.000148	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP1B1—esophageal cancer	1.96e-05	0.000147	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.91e-05	0.000143	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.91e-05	0.000143	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—TPI1—esophageal cancer	1.91e-05	0.000143	CbGpPWpGaD
Prednisone—ALB—Metabolism—HMOX1—esophageal cancer	1.87e-05	0.00014	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP19A1—esophageal cancer	1.84e-05	0.000138	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.84e-05	0.000138	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.83e-05	0.000137	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.8e-05	0.000135	CbGpPWpGaD
Prednisone—ALB—Metabolism—ABCB1—esophageal cancer	1.8e-05	0.000135	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.76e-05	0.000132	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.74e-05	0.000131	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—HMOX1—esophageal cancer	1.68e-05	0.000126	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—EP300—esophageal cancer	1.67e-05	0.000125	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GNG7—esophageal cancer	1.66e-05	0.000124	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.65e-05	0.000124	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—HMOX1—esophageal cancer	1.64e-05	0.000123	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ABCB1—esophageal cancer	1.61e-05	0.000121	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.55e-05	0.000116	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—MYC—esophageal cancer	1.49e-05	0.000112	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CA—esophageal cancer	1.49e-05	0.000112	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.48e-05	0.000111	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.46e-05	0.000109	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TP53—esophageal cancer	1.44e-05	0.000108	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ENO1—esophageal cancer	1.38e-05	0.000104	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.38e-05	0.000104	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PSME2—esophageal cancer	1.36e-05	0.000102	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PSME1—esophageal cancer	1.36e-05	0.000102	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.36e-05	0.000102	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CA—esophageal cancer	1.24e-05	9.28e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.22e-05	9.14e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—CREBBP—esophageal cancer	1.2e-05	9e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.18e-05	8.82e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.11e-05	8.3e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CREBBP—esophageal cancer	1.08e-05	8.08e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—NOS3—esophageal cancer	1.07e-05	8.05e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CREBBP—esophageal cancer	1.05e-05	7.88e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.01e-05	7.57e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTGS2—esophageal cancer	9.83e-06	7.37e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ABCB1—esophageal cancer	9.69e-06	7.27e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—NOS3—esophageal cancer	9.64e-06	7.23e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—NOS3—esophageal cancer	9.41e-06	7.06e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTGS2—esophageal cancer	8.82e-06	6.61e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTGS2—esophageal cancer	8.61e-06	6.45e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—EP300—esophageal cancer	8.17e-06	6.13e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—EP300—esophageal cancer	7.34e-06	5.5e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—EP300—esophageal cancer	7.16e-06	5.37e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CREBBP—esophageal cancer	6.48e-06	4.86e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CA—esophageal cancer	6.05e-06	4.53e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—NOS3—esophageal cancer	5.8e-06	4.35e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CA—esophageal cancer	5.43e-06	4.07e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTGS2—esophageal cancer	5.3e-06	3.98e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CA—esophageal cancer	5.3e-06	3.97e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—EP300—esophageal cancer	4.41e-06	3.31e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CA—esophageal cancer	3.26e-06	2.45e-05	CbGpPWpGaD
